Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?

Jenneke Leentjens, Mike Peters, Anne C. Esselink, Yvo Smulders, Cornelis Kramers

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	2356-2366
Number of pages	11
Journal	British Journal of Clinical Pharmacology
Volume	83
Issue number	11
DOIs	https://doi.org/10.1111/bcp.13340
Publication status	Published - Nov 2017

Access to Document

@article{a02fcf802b1047d2a42460a7e555ccf9,

title = "Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?",

keywords = "anticoagulation, DOAC, LMWH, pulmonary embolism, unfractionated heparin",

author = "Jenneke Leentjens and Mike Peters and Esselink, {Anne C.} and Yvo Smulders and Cornelis Kramers",

year = "2017",

month = nov,

doi = "10.1111/bcp.13340",

language = "English",

volume = "83",

pages = "2356--2366",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",